ESBD_File_341623_Memorandum (Opioid Products; 10-25-23).pdf

PDF 209 KB Posted

Attached to
RFP for Opioid Use Disorder Treatment Medications
Solicitation number
R2270-2023-7
Issued by
Travis County, Austin City, Texas

About this file

This document is a memorandum from Integral Care regarding a Request for Proposal (RFP) for the sale of opioid use disorder treatment medications, including methadone, buprenorphine, and buprenorphine/naloxone. The RFP is open to all interested parties, with Historically Underutilized Businesses, including Minority-Owned Businesses and Women-Owned Businesses, encouraged to apply. The deadline to submit a proposal is 5:00 p.m. CDT on December 19, 2023. Integral Care has provided the purchase history for the requested items, including NDC numbers and quantities purchased, to assist potential bidders. The RFP covers the jurisdictions of Travis County and the City of Austin, Texas.

The memorandum also includes pricing and quantity information for the specific medication products requested, including methadone liquid and buprenorphine sublingual tablets. No other details regarding pricing terms, set asides, incumbents, funding requirements, or sources are provided.

View the file

Other files

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

MEMORANDUM

TO: All Persons/Entities That Have Received Integral Care’s October 25, 2023

Request for Proposal for Opiod Substance Use Disorder Treatment Medications

(“RFP”)

FROM: Brody Ballard, Coordinator of Legal Services

RE: Responses to Questions Regarding RFP

DATE: December 5, 2023

QUESTIONS/RESPONSES

Q1: We’d like to ask for your consideration of sharing Integral Care’s previous years’ purchase history for the items being requested, including NDC # and total qty. purchased.

A: Since December of 2022 to date, Integral Care has the following purchase history:

1. Methadone liquid NDC 00406052710 872 bottles (8720000 ml/mg)

2. buprenorphine sublingual tablets

NDC 62756-459-83 2mg - 88 bottles (5280 mgs)

NDC 62756-460-83 8mg - 300 bottles (72000 mgs)

File details come from the government source that posted it. Updated .